Company Filing History:
2 out of 16 
1 out of 447 
1 out of 4,126 
Years Active: 1992-2005
Title: Innovations of John Samuel
Introduction
John Samuel is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of therapeutic agents, particularly in the development of methods and compositions that enhance the efficacy of polyene antibiotics while reducing their toxicity. With a total of 4 patents to his name, Samuel's work has the potential to impact medical treatments significantly.
Latest Patents
One of Samuel's latest patents is titled "Methods and compositions for polyene antibiotics with reduced toxicity." This invention provides methods and compositions aimed at reducing the toxicity of hydrophobic therapeutic agents, especially polyene antibiotics like Amphotericin B (AmB). The patent details the incorporation of these agents within micelles made from an amphiphilic block-forming copolymer. The formulation includes specific molecular structures that optimize the therapeutic effects while minimizing adverse reactions. Another significant patent is the "Method for eliciting Th1-specific immune response." This method involves the administration of a slow-release vehicle containing an antigenic peptide and a Th1 specific immunomodulator, designed to treat Th1 mediated disease states effectively.
Career Highlights
Throughout his career, John Samuel has worked with reputable organizations, including Biomira, Inc. and the University of Alberta. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include B Michael Longenecker and Glen Kwon. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
John Samuel's contributions to the field of medicine through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic agents, showcasing the importance of innovation in healthcare.